• MK-0812: Advancing Monocyte Trafficking Inhibition in MASH M

  2026-05-29

  MK-0812 enables precise, reproducible blockade of monocyte recruitment, making it an indispensable tool for dissecting CCR2-mediated inflammation in metabolic dysfunction-associated steatohepatitis (MASH) models. Its potency and selectivity streamline experimental workflows, from gut–liver axis studies to high-content immune profiling, with robust troubleshooting strategies to ensure consistent results.

• Enhanced Lysosomal Exocytosis in MPS IVA Cartilage Pathology

  2026-05-29

  This study elucidates how enhanced lysosomal exocytosis and growth factor signaling disruptions contribute to cartilage pathology in a zebrafish model of mucopolysaccharidosis type IVA (MPS IVA). By moving beyond the traditional focus on substrate accumulation, the research highlights new mechanistic links between lysosomal membrane dynamics, protease secretion, and skeletal disease progression.

• SARS-CoV-2 Nucleocapsid Disrupts GADD34-Driven Antiviral Def

  2026-05-28

  Liu et al. reveal that the SARS-CoV-2 nucleocapsid protein impairs the host's innate immune response by sequestering GADD34 mRNA into atypical stress foci, thereby blocking IRF3-mediated interferon production. These findings clarify a novel viral strategy for immune evasion and have implications for understanding coronavirus pathogenesis and potential intervention points.

• CB-5083: Disrupting Protein Homeostasis for Cancer Innovatio

  2026-05-28

  Explore how CB-5083, a potent p97 inhibitor, redefines the landscape of protein homeostasis disruption in translational cancer research. This thought-leadership article bridges mechanistic insights with actionable guidance for researchers, contextualizing the product’s value in light of new findings on the p97-cGAS axis and cross-species DNA repair mechanisms.

• Cycloheximide: Translational Strategies for Targeting Protei

  2026-05-27

  Cycloheximide, a potent protein biosynthesis inhibitor, is central to dissecting protein turnover and cell fate in advanced translational research. This thought-leadership article bridges mechanistic insights with strategic assay guidance, highlighting the compound's role in apoptosis, fibrosis, and disease modeling. By integrating recent findings—including the antifibrotic targeting of USP4 in renal fibrosis—and referencing both APExBIO’s high-purity Cycloheximide and emerging literature, we chart pathways for impactful experimental design and translational discovery.

• Microbiota Interventions and Neuroinflammation in Hepatic En

  2026-05-27

  This study utilized [18F]PBR146 PET imaging to evaluate the efficacy of Bifidobacterium and fecal microbiota transplantation (FMT) in reducing neuroinflammation in a rat model of chronic hepatic encephalopathy (HE). The research revealed that Bifidobacterium, but not FMT, significantly inhibited neuroinflammation in specific brain regions, highlighting the nuanced impact of gut-targeted therapies on the gut–liver–brain axis.

• Single-Base 5hmC Mapping Reveals Context-Dependent Roles in

  2026-05-26

  This study delivers the first single-base resolution map of 5-hydroxymethylcytosine (5hmC) in rice, revealing its dynamic, context-dependent regulatory roles during drought stress adaptation. The findings provide a mechanistic foundation for future research into plant epigenetic responses and the development of resilient crops.

• Alda 1: ALDH2 Activator Workflows for Cardiac and Dermatitis

  2026-05-26

  Alda 1 enables targeted activation of ALDH2, offering double-digit fold enzymatic enhancement even in impaired variants. This article translates the latest mechanistic breakthroughs into actionable protocols for advancing cardiac ischemia and radiation dermatitis research.

• Digestive Transformations of Withania somnifera Bioactives M

  2026-05-25

  This study provides a detailed LC-MS/MS-based analysis of how key Withania somnifera (ashwagandha) bioactives are transformed under simulated digestive conditions, highlighting compound-specific stability and metabolic lability. The findings refine in vitro modeling of botanical pharmacokinetics and inform future preclinical research on complex herbal extracts.

• Bacterial Effector NleE Disrupts ZPR1 Phase Separation to In

  2026-05-25

  Ouyang et al. (2023) uncover a mechanism by which the EPEC effector NleE disrupts the liquid-liquid phase separation (LLPS) of the host zinc finger protein ZPR1, thereby antagonizing the unfolded protein response of the endoplasmic reticulum (UPRER). This work highlights the value of chemical crosslinkers for studying transient protein interactions and provides a foundation for future research on host-pathogen interactions and transcriptional regulation.

• Prevotella copri Depletes IPyA to Accelerate Breast Cancer P

  2026-05-24

  A recent study demonstrates that Prevotella copri, enriched in the gut microbiota of breast cancer patients, accelerates tumor growth by depleting host indole-3-pyruvic acid (IPyA) and inactivating AMPK via UHRF1-mediated mechanisms. These findings clarify a direct microbiota-metabolite-tumor axis and suggest new avenues for targeting breast cancer progression.

• Optimizing mRNA Workflows: Scenario-Driven Guidance with Pse

  2026-05-23

  This article delivers an evidence-based, scenario-driven guide for biomedical researchers seeking to enhance mRNA synthesis, cell assay reproducibility, and immunogenicity profiles using Pseudo-UTP (SKU B7972). Drawing from recent literature and emphasizing real laboratory challenges, we examine how Pseudo-UTP addresses RNA stability, translation efficiency, and product reliability. Practical protocol parameters and vendor selection insights empower bench scientists to make informed, workflow-optimized decisions.

• Applied Workflows with mCherry mRNA: Enhanced Red Fluorescen

  2026-05-22

  EZ Cap™ mCherry mRNA (5mCTP, ψUTP) empowers researchers with robust, immune-evasive red fluorescent protein expression for high-precision live-cell tracking and quantitative reporter assays. Its Cap 1 structure and nucleotide modifications enable reproducible results even in sensitive or immune-competent cell systems. Explore actionable workflows, troubleshooting, and the latest comparative insights for optimal deployment.

• Digestive Metabolomics of Ashwagandha: LC-MS/MS Reveals Key

  2026-05-22

  This study applies advanced LC-MS/MS and metabolomics to map how Withania somnifera (ashwagandha) extracts are chemically transformed under simulated digestive conditions. The research clarifies the stability and biotransformation of major withanolides, informing the development of more predictive in vitro models for botanical pharmacokinetics.

• Cy5 TSA Fluorescence System Kit: Amplify Sensitivity in IHC

  2026-05-21

  The Cy5 TSA Fluorescence System Kit empowers researchers to detect low-abundance targets in immunohistochemistry, immunocytochemistry, and in situ hybridization with up to 100-fold signal amplification. Its rapid, HRP-catalyzed workflow ensures reproducible, high-resolution imaging—enabling breakthrough insights in cancer and cellular biology.

486 records 12/33 page Previous Next First page 上5页 1112131415 下5页 Last page